Traders Stock tips

StockTipWeekly.com

One New Stock Market Pick Each Week
To Build Your Winning Stock Trading Profits


Swing Trading Stocks

Your Ad Here

STW Biotech Stock
Reports & Analysis
BCRX    EP 4.74
CXM        EP .42
BDSI      EP 2.30
PPHM    EP 1.63
OREX     EP 4.14
ACTC      EP.073
TTNP     EP 1.03
SIGA      EP 6.67
XOMA     EP .46
GNBT       EP .36

Stock Trade of the Day
WEEK!

SIGA
- Will run to $23+ on
BARDA Contract-Buy 5-16-11






GNBT Stock Update 6-15-10

GNBT fell the day we made this recommendation along with most other small cap biotech stocks and the overall market. If you took a position the afternoon we made the GNBT recommendation you should have a great entry point of about .36 giving you even more profit potential than we targeted.

Though GNBT stock has traded in this lower range between .35 and .37 for the past week none of the factors that lead STW to pick GNBT have changed. We reiterate our BUY Recommendation on GNBT.


This Weeks Stock Pick - Swing Trading Tip

6-7-2010 Trading Recommendation GNBT - Buy

Our penny stock swing trading tip for the week beginning  6-7-2010 is a biotech stock we have watched for over a year and believe feel is bottoming and reaching an oversold price in spite of several great bits of news on its current FDA trials and pipeline. This company is GNBT. It has recently bounced off a low in the .31 range and we are building a position between .36 and .41 per share. The share price trend is now moving up and we believe that the recent positive trials and news will help shares of GNBT break thru resistance around .44 and when that happens in the near future the share price will move back to the mid .60ís giving a nice .20+ per share profit with a return near 50%.

The recent news on GNBT is positive interim results on Oral-Lyn spray Phase III results could push GNBT towards the one dollar mark over the next few months; and if the Phase III results result in FDA approval next year I expect a big move from this stock because the Oral-Lyn spray that delivers insulin through the inner lining of the cheek and results show that this is superior to traditional insulin delivery methods being used by diabetics.

The Cancer program of GNBT is also showing promising results that have just been presented at the prestigious 2010 ASCO meetings. GNBT has also recently been granted several new patents and is beginning to receive cash flow on foreign sales of some of its older programs.

We are long GNBT.


Here is the companies published overview and 1 year chart with some TA included:

GNBT - Generex Biotechnology Corporation is a development stage company in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The companyís products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporationís under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum. The company was founded in 1983 and is based in Toronto, Canada.
 

GNBT 6-7-10

Moving Average Price Compare GNBT is trading above its 13 day moving average. This is a bullish trend. There is added weight to this indication because the moving average is rising and suggests that there is buying interest in this stock.

Bollinger Bands GNBT is trading within its Bollinger Bands. This is a normal condition and suggests that the stock is neither overbought nor oversold.

MACD GNBT is currently indicating a weak bullish signal.

On Balance Volume The On Balance Volume shows that longer term selling pressure has given way to near term accumulation.

Directional Movement Index Today's trading has caused the +DI line to rise above the -DI line. This is a bullish signal.

 

STW Biotech
Stock Watch List


CBAID
ACTC
SIGA
ULU
CTSO

 


Sign Up
For STW Email
Trading Alerts

 


 

| HomeThis Weeks Tip | About Our Picks | Market research | Privacy-Terms |

Stocktipweekly.com©2006-2010      Contact: Info@stocktipweekly.com      Website Managed by TRM Daytona Beach, Florida

This website is for information purposes only. All stock market investments have risk and may increase or decline. The management of this site is not responsible for any profit or loss you experience, do your own due diligence an any company before investing, our stock tips are only a starting point, you are ultimately responsible for your own investment decisions.